Owner Bristol-Myers Squibb Company

Inventors Lee, Francis Y; Bol, David K; Wong, Tai W; Rowley, Ronald B; Carboni, Joan M

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003218236

PCT Number PCT/US03/08278

PCT Pub. Number WO2003/073841

Priority 60/360,889 01.03.02 US

Filing date 3 March 2003

Wipo publication date 16 September 2003

Acceptance publication date 6 December 2007

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine